McKesson (MCK) is an Incredible Growth Stock: 3 Reasons Why

03.06.25 18:45 Uhr

Werte in diesem Artikel
Aktien

SGD 0,00 SGD 0,00%

620,00 EUR -7,00 EUR -1,12%

Indizes

5.966,8 PKT -4,0 PKT -0,07%

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.McKesson (MCK) is one such stock that our proprietary system currently recommends. The company not only has a favorable Growth Score, but also carries a top Zacks Rank.Research shows that stocks carrying the best growth features consistently beat the market. And returns are even better for stocks that possess the combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy).While there are numerous reasons why the stock of this prescription drug distributor is a great growth pick right now, we have highlighted three of the most important factors below:Earnings GrowthEarnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. And for growth investors, double-digit earnings growth is definitely preferable, and often an indication of strong prospects (and stock price gains) for the company under consideration.While the historical EPS growth rate for McKesson is 16%, investors should actually focus on the projected growth. The company's EPS is expected to grow 12.5% this year, crushing the industry average, which calls for EPS growth of 8.2%.Impressive Asset Utilization RatioGrowth investors often overlook asset utilization ratio, also known as sales-to-total-assets (S/TA) ratio, but it is an important feature of a real growth stock. This metric exhibits how efficiently a firm is utilizing its assets to generate sales.Right now, McKesson has an S/TA ratio of 4.95, which means that the company gets $4.95 in sales for each dollar in assets. Comparing this to the industry average of 0.77, it can be said that the company is more efficient.In addition to efficiency in generating sales, sales growth plays an important role. And McKesson is well positioned from a sales growth perspective too. The company's sales are expected to grow 13% this year versus the industry average of 3.2%.Promising Earnings Estimate RevisionsBeyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.The current-year earnings estimates for McKesson have been revising upward. The Zacks Consensus Estimate for the current year has surged 1.7% over the past month.Bottom LineMcKesson has not only earned a Growth Score of A based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #2 because of the positive earnings estimate revisions.You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.This combination positions McKesson well for outperformance, so growth investors may want to bet on it.Don’t Miss Out on These Stocks Before you make your next investing move, we have a free report that highlights the %%CTA_TEXT%% to buy.Our experts at Zacks Investment Research hand-selected these stocks for their eye-opening growth projections.Since 1988, our stock picks have more than doubled the S&P 500 with an average gain of +23.89% per year using the Zacks Rank stock-rating system.Register now to see the %%CTA_TEXT%%.7 best stocksWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report McKesson Corporation (MCK): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: McKesson und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Incredible

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Incredible

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu McKesson Corp.

Wer­bung

Analysen zu McKesson Corp.

DatumRatingAnalyst
05.08.2019McKesson Peer PerformWolfe Research
26.10.2018McKesson Equal WeightBarclays Capital
20.07.2018McKesson NeutralRobert W. Baird & Co. Incorporated
08.03.2018McKesson Equal WeightBarclays Capital
02.02.2018McKesson NeutralMizuho
DatumRatingAnalyst
23.01.2018McKesson BuyNeedham & Company, LLC
04.12.2017McKesson BuyDeutsche Bank AG
01.11.2017McKesson BuyNeedham & Company, LLC
25.10.2017McKesson BuyNeedham & Company, LLC
19.09.2017McKesson OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
05.08.2019McKesson Peer PerformWolfe Research
26.10.2018McKesson Equal WeightBarclays Capital
20.07.2018McKesson NeutralRobert W. Baird & Co. Incorporated
08.03.2018McKesson Equal WeightBarclays Capital
02.02.2018McKesson NeutralMizuho
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für McKesson Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen